Regulation of ferroptosis in cancer cells by YAP/TAZ and Hippo pathways: The therapeutic implications

Ferroptosis is a novel form of iron-dependent cell death characterized by lipid peroxidation. While the importance and disease relevance of ferroptosis is gaining recognition, much remains unknown about various genetic and non-genetic determinants of ferroptosis. Hippo signaling pathway is an evolut...

Full description

Bibliographic Details
Main Authors: Tianai Sun, Jen-Tsan Chi
Format: Article
Language:English
Published: KeAi Communications Co., Ltd. 2021-05-01
Series:Genes and Diseases
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2352304220300696
_version_ 1797721807389720576
author Tianai Sun
Jen-Tsan Chi
author_facet Tianai Sun
Jen-Tsan Chi
author_sort Tianai Sun
collection DOAJ
description Ferroptosis is a novel form of iron-dependent cell death characterized by lipid peroxidation. While the importance and disease relevance of ferroptosis is gaining recognition, much remains unknown about various genetic and non-genetic determinants of ferroptosis. Hippo signaling pathway is an evolutionarily conserved pathway that responds to various environmental cues and controls organ size, cell proliferation, death, and self-renewal capacity. In cancer biology, Hippo pathway is a potent tumor suppressing mechanism and its dysregulation contributes to apoptosis evasion, cancer development, metastasis, and treatment resistance. Hippo dysregulation leads to aberrant activation of YAP and TAZ, the two major transcription co-activators of TEADs, that induce the expression of genes triggering tumor-promoting phenotypes, including enhanced cell proliferation, self-renewal and apoptosis inhibition. The Hippo pathway is regulated by the cell-cell contact and cellular density/confluence. Recently, ferroptosis has also been found being regulated by the cellular contact and density. The YAP/TAZ activation under low density, while confers apoptosis resistance, renders cancer cells sensitivity to ferroptosis. These findings establish YAP/TAZ and Hippo pathways as novel determinants of ferroptosis. Therefore, inducing ferroptosis may have therapeutic potential for YAP/TAZ-activated chemo-resistant and metastatic tumor cells. Reciprocally, various YAP/TAZ-targeting treatments under clinical development may confer ferroptosis resistance, limiting the therapeutic efficacy.
first_indexed 2024-03-12T09:38:34Z
format Article
id doaj.art-d54f6cecbc4e448196adf3b98d49262c
institution Directory Open Access Journal
issn 2352-3042
language English
last_indexed 2024-03-12T09:38:34Z
publishDate 2021-05-01
publisher KeAi Communications Co., Ltd.
record_format Article
series Genes and Diseases
spelling doaj.art-d54f6cecbc4e448196adf3b98d49262c2023-09-02T13:27:37ZengKeAi Communications Co., Ltd.Genes and Diseases2352-30422021-05-0183241249Regulation of ferroptosis in cancer cells by YAP/TAZ and Hippo pathways: The therapeutic implicationsTianai Sun0Jen-Tsan Chi1Department of Molecular Genetics and Microbiology, Duke University School of Medicine, Durham, NC, 27710, USA; Center for Genomic and Computational Biology, Duke University School of Medicine, Durham, NC, 27710, USADepartment of Molecular Genetics and Microbiology, Duke University School of Medicine, Durham, NC, 27710, USA; Center for Genomic and Computational Biology, Duke University School of Medicine, Durham, NC, 27710, USA; Corresponding author. 101 Science Drive, DUMC 3382, CIEMAS, 2177A, Duke Medical School, Durham, NC 27708, USA.Ferroptosis is a novel form of iron-dependent cell death characterized by lipid peroxidation. While the importance and disease relevance of ferroptosis is gaining recognition, much remains unknown about various genetic and non-genetic determinants of ferroptosis. Hippo signaling pathway is an evolutionarily conserved pathway that responds to various environmental cues and controls organ size, cell proliferation, death, and self-renewal capacity. In cancer biology, Hippo pathway is a potent tumor suppressing mechanism and its dysregulation contributes to apoptosis evasion, cancer development, metastasis, and treatment resistance. Hippo dysregulation leads to aberrant activation of YAP and TAZ, the two major transcription co-activators of TEADs, that induce the expression of genes triggering tumor-promoting phenotypes, including enhanced cell proliferation, self-renewal and apoptosis inhibition. The Hippo pathway is regulated by the cell-cell contact and cellular density/confluence. Recently, ferroptosis has also been found being regulated by the cellular contact and density. The YAP/TAZ activation under low density, while confers apoptosis resistance, renders cancer cells sensitivity to ferroptosis. These findings establish YAP/TAZ and Hippo pathways as novel determinants of ferroptosis. Therefore, inducing ferroptosis may have therapeutic potential for YAP/TAZ-activated chemo-resistant and metastatic tumor cells. Reciprocally, various YAP/TAZ-targeting treatments under clinical development may confer ferroptosis resistance, limiting the therapeutic efficacy.http://www.sciencedirect.com/science/article/pii/S2352304220300696ApoptosisFerroptosisHippo pathwayTranscriptional coactivator with PDZ-binding motif (TAZ)Yes-associated protein 1 (YAP1)
spellingShingle Tianai Sun
Jen-Tsan Chi
Regulation of ferroptosis in cancer cells by YAP/TAZ and Hippo pathways: The therapeutic implications
Genes and Diseases
Apoptosis
Ferroptosis
Hippo pathway
Transcriptional coactivator with PDZ-binding motif (TAZ)
Yes-associated protein 1 (YAP1)
title Regulation of ferroptosis in cancer cells by YAP/TAZ and Hippo pathways: The therapeutic implications
title_full Regulation of ferroptosis in cancer cells by YAP/TAZ and Hippo pathways: The therapeutic implications
title_fullStr Regulation of ferroptosis in cancer cells by YAP/TAZ and Hippo pathways: The therapeutic implications
title_full_unstemmed Regulation of ferroptosis in cancer cells by YAP/TAZ and Hippo pathways: The therapeutic implications
title_short Regulation of ferroptosis in cancer cells by YAP/TAZ and Hippo pathways: The therapeutic implications
title_sort regulation of ferroptosis in cancer cells by yap taz and hippo pathways the therapeutic implications
topic Apoptosis
Ferroptosis
Hippo pathway
Transcriptional coactivator with PDZ-binding motif (TAZ)
Yes-associated protein 1 (YAP1)
url http://www.sciencedirect.com/science/article/pii/S2352304220300696
work_keys_str_mv AT tianaisun regulationofferroptosisincancercellsbyyaptazandhippopathwaysthetherapeuticimplications
AT jentsanchi regulationofferroptosisincancercellsbyyaptazandhippopathwaysthetherapeuticimplications